Skip to main content

Table 3 Cell apoptosis after bortezomib treatment

From: Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

Cell line

Group

Cell apoptosis rate (%)

Total

Early-stage

Late-stage

U251

Control

5.78 ± 1.34

2.56 ± 0.44

3.22 ± 0.26

10 nmol/L Bor

14.01 ± 1.33

5.68 ± 1.42

8.33 ± 1.51

20 nmol/L Bor

23.07 ± 3.21

13.49 ± 1.97

9.58 ± 2.50

U87

Control

11.62 ± 2.12

6.02 ± 1.08

5.58 ± 1.86

10 nmol/L Bor

28.03 ± 31.34

21.08 ± 1.52

6.95 ± 0.21

20 nmol/L Bor

41.17 ± 2.55

31.48 ± 2.97

10.23 ± 0.93